The drug, delivered by EMS as a single injection, improved infarct-related patency at cath lab arrival and 30-day clinical outcomes.
One year of treatment with either of two strong blood-thinning medications—ticagrelor and prasugrel—by people with type 1 or ...
Rapid treatment with CeleCor Therapeutics' investigational heart-attack drug, zalunfiban, resulted in higher levels of blood flow to the heart and an approximately 21% reduction in a patient's risk of ...
How Metamaterial Design Could Give Interventional Cardiologists Finer Control in Complex Heart Surgeries Coronary artery disease afflicts 18 million ...
For optimal 1-year results, in patients with prior coronary artery bypass grafting who need percutaneous coronary ...
View the full release here: "With a similar safety profile, OPN can be a feasible and faster alternative to IVL." Dr. M. Bossard, Senior Physician at Luzerner Kantonsspital, Switzerland A total of ...
In the treatment of larger narrowed blood vessels, drug-coated balloon catheters have been shown to deliver lasting and ...
This news was covered by the Medical Dialogues Bureau, which was present at the TCT Conference 2025 held in San Francisco, ...
Abu Dhabi: The Heart Failure and Transplant Department at Cleveland Clinic Abu Dhabi performed 574 heart surgeries in 2024, according to Dr. Nadya Al Matroushi, Consultant in Cardiovascular Medicine ...
A new drug-eluting balloon can perform just as well as the standard treatment for patients with coronary in-stent restenosis ...
Physicians will remain in the loop, but AI can “turbocharge and augment our abilities,” an emergency medicine physician says.
This news is covered by the Medical Dialogues Bureau present at the TCT Conference 2025, being held in San Francisco, USA.An ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback